Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
12.39
-0.11 (-0.88%)
Oct 29, 2025, 4:00 PM EDT - Market closed
Crescent Biopharma Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$25.60
Upside
+106.62%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +101.78% | Aug 27, 2025 |
| Jefferies | Jefferies | Strong Buy Initiates $26 | Strong Buy | Initiates | $26 | +109.85% | Aug 25, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $25 | Strong Buy | Initiates | $25 | +101.78% | Aug 11, 2025 |
| Wedbush | Wedbush | Buy Initiates $27 | Buy | Initiates | $27 | +117.92% | Jul 14, 2025 |
| Stifel | Stifel | Strong Buy Initiates $28 | Strong Buy | Initiates | $28 | +125.99% | Jun 25, 2025 |
| LifeSci Capital | LifeSci Capital | Buy Initiates $22 | Buy | Initiates | $22 | +77.56% | Jun 18, 2025 |
| Raymond James | Raymond James | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Nov 15, 2021 |
| Raymond James | Raymond James | Buy Maintains $285 → $270 | Buy | Maintains | $285 → $270 | +2,079.18% | Aug 6, 2021 |
| Raymond James | Raymond James | Buy Maintains $270 → $285 | Buy | Maintains | $270 → $285 | +2,200.24% | Apr 29, 2021 |
| Piper Sandler | Piper Sandler | Buy Initiates $225 | Buy | Initiates | $225 | +1,715.98% | Feb 10, 2021 |
| Raymond James | Raymond James | Buy Maintains $300 → $270 | Buy | Maintains | $300 → $270 | +2,079.18% | Feb 4, 2021 |
| B. Riley Securities | B. Riley Securities | Strong Buy → Hold Downgrades $660 → $188 | Strong Buy → Hold | Downgrades | $660 → $188 | +1,413.32% | Jun 21, 2018 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $285 → $735 | Strong Buy | Maintains | $285 → $735 | +5,832.20% | Feb 12, 2018 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $150 → $1,125 | Strong Buy | Maintains | $150 → $1,125 | +8,979.90% | Feb 9, 2018 |
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates $285 | Strong Buy | Initiates | $285 | +2,200.24% | Dec 8, 2017 |
| Chardan Capital | Chardan Capital | Strong Buy Initiates $150 | Strong Buy | Initiates | $150 | +1,110.65% | Jun 12, 2017 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.